Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Radix scutellariae + aluminum is a combination of the dried root of Scutellaria baicalensis (commonly known as Baikal skullcap or Huang Qin) and an unspecified form of aluminum. Radix scutellariae is a traditional Chinese medicinal herb rich in flavonoids such as baicalin, wogonoside, and baicalein, which have demonstrated anti-inflammatory, antioxidant, antitumor, and detoxifying properties[1][3]. The mechanism of action for radix scutellariae includes inhibition of the toll-like receptor 4/nuclear factor-kappa B (TLR4/NF-κB) signaling pathway via active components like oroxylin A[1]. Aluminum compounds are sometimes used in pharmaceuticals as adjuvants or antacids but can also be toxic depending on dose and formulation. There is no evidence from the provided sources that this specific combination (radix scutellariae + aluminum) exists as an approved pharmaceutical product; it may represent a non-standardized supplement or experimental preparation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on radix scutellariae + aluminum.